Abstract
It has become an increasingly important task for the current society to accelerate the pace of the construction of digital society and pay attention to creating new advantages of digital economy. Since the outbreak of the coronavirus disease 2019 (COVID-19), many enterprises have faced production interruption, frequent supply chain obstruction, and the stage process of resuming production. Many enterprises’ industry status has also been severely affected, operating costs have skyrocketed, and prof it margins have continued to be squeezed. In addition, with the continuous deepening of the pharmaceutical reform, the management system of pharmaceutical enterprises is in urgent need of updating, and internal innovation and change are imperative. Digital transformation will be an important measure for pharmaceutical enterprises to optimize the industrial structure and adapt to the era of policy.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call